Saito S, Matsui S, Watanabe M, Waga T, Kajiwara Y, Shirota M, Iijima M, Kitabatake K
Central Research Laboratories, Asahi Breweries, Ltd., Tokyo, Japan.
Arzneimittelforschung. 1990 Mar;40(3):257-60.
A series of novel L-alanyl- and L-lysyl-L-proline derivatives having an omega-amino-1-carboxyalkyl group was prepared, and assayed for their inhibitory activity against angiotensin converting enzyme (ACE). The dicarboxylic acids possesing S,S,S configuration showed potent in vitro ACE inhibitory activity with IC50 values of 0.68-1.4 nmol/l. The length of the carbon chain in the omega-aminoalkyl moiety was varied from 6 to 9 to investigate the optimal structure for long-acting ACE inhibitors. The most prolonged activity in vivo was observed with N-[8-amino-1(s)-carboxyoctyl]-L-alanyl-L-proline upon i.v. and p.o.